COMPANY

Elixir Medical

HQ: Milpitas, CA source · elixirmedical.com ↗

FDA-cleared device company Clinical Phase 3

Keywords: peripheral artery disease Coronary Artery Disease Coronary Artery Stenosis Chronic Total Occlusion of Coronary Artery Bifurcation of Coronary Artery Multi Vessel Coronary Artery Disease Long Lesions Coronary Artery Disease Coronary Disease Coronary Stenosis Ischemic Heart Disease Peripheral Vascular Disease Percutaneous Coronary Intervention

Location: Milpitas, CA · source · Oct 15, 2026

Profile checked Oct 10, 2026

18Trials (company is sponsor)

Timeline

Mar 10, 2024 Trial start —: DynamX Bioadaptor Global Post-Market Registry: Clinical Trial of the Elixir Medical DynamX Coronary Bioadaptor System source ↗
Apr 27, 2023 Trial start Not phased (device or behavioral study): A Clinical Trial to Assess the Elixir Medical LithiX Coronary Hertzian Contact Intravascular Lithotripsy Catheter source ↗
Dec 15, 2021 Trial start Phase 2: The DESyne BDS Plus RCT: A Randomized Clinical Trial to Assess the Elixir DESyne BDS Plus Drug Eluting Coronary Stent System for the Treatment of de Novo Native Coronary Artery Lesions source ↗
Oct 19, 2021 Trial start Not phased (device or behavioral study): DYNAMX Bioadaptor ImplanTation for the trEatment of Complex Coronary Lesions source ↗
Dec 16, 2020 Trial start Not phased (device or behavioral study): The Elixir Bioadaptor vs. The Onyx Stent in De Novo Native Coronary Arteries source ↗
Sep 30, 2020 Trial start Phase 4: DynamX Bioadaptor Hong Kong Registry source ↗
Sep 30, 2020 Trial start Not phased (device or behavioral study): Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT) source ↗
Sep 1, 2020 Trial start Not phased (device or behavioral study): DESyne X2 Post Market Follow-up Study source ↗
Dec 10, 2018 Trial start Not phased (device or behavioral study): DynamX Sirolimus Study Sirolimus Eluting Coronary Bioadaptor System source ↗
Nov 16, 2017 Trial start Not phased (device or behavioral study): Evaluation of a Thin Strut Metallic Stent: the Elixir DynamX Clinical Study source ↗
Oct 10, 2016 Trial start Not phased (device or behavioral study): The DESappear Study: Drug Eluting Scaffold source ↗
Jan 20, 2016 Trial start Not phased (device or behavioral study): Elixir Medical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - Cx Registry source ↗
May 13, 2015 Trial start —: DESolve® X-Pand Global Post Market Registry source ↗
Apr 22, 2014 Trial start Not phased (device or behavioral study): DESolve Post-Approval Study source ↗
Feb 26, 2014 Trial start Not phased (device or behavioral study): EXCELLA Post-Approval Study source ↗
2011-11 Trial start Not phased (device or behavioral study): Elixir Medical Clinical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - The DESolve Nx Trial source ↗
2011-02 Trial start Not phased (device or behavioral study): Elixir Medical Clinical Evaluation of the DESolve Myolimus Eluting Bioresorbable Coronary Stent System - DESolve I Trial source ↗
2008-10 Trial start Not phased (device or behavioral study): Elixir Medical Clinical Evaluation of the Novolimus-Eluting Coronary Stent System: A Randomized Study "EXCELLA II STUDY" source ↗

Upcoming milestones

2028-12 (ESTIMATED) · · DynamX Bioadaptor Global Post-Market Registry: Clinical Trial of the Elixir Medical DynamX Coronary Bioadaptor System · NCT06074549

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 18

Record	Title	Phase	Status	Start	Primary completion
NCT05464147	DYNAMX Bioadaptor ImplanTation for the trEatment of Complex Coronary Lesions	Not phased (device or behavioral study)	Completed	Oct 19, 2021	Aug 1, 2024 (actual)
NCT06074549	DynamX Bioadaptor Global Post-Market Registry: Clinical Trial of the Elixir Medical DynamX Coronary Bioadaptor System	Not listed	Recruiting	Mar 10, 2024	2028-12 (estimated)
NCT04192747	The Elixir Bioadaptor vs. The Onyx Stent in De Novo Native Coronary Arteries	Not phased (device or behavioral study)	Active, not recruiting	Dec 16, 2020	Feb 28, 2023 (actual)
NCT05828173	A Clinical Trial to Assess the Elixir Medical LithiX Coronary Hertzian Contact Intravascular Lithotripsy Catheter	Not phased (device or behavioral study)	Completed	Apr 27, 2023	Mar 29, 2024 (actual)
NCT04483791	DynamX Bioadaptor Hong Kong Registry	Phase 4	Completed	Sep 30, 2020	Dec 31, 2022 (actual)
NCT04562805	Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)	Not phased (device or behavioral study)	Active, not recruiting	Sep 30, 2020	Sep 5, 2024 (actual)
NCT05033964	The DESyne BDS Plus RCT: A Randomized Clinical Trial to Assess the Elixir DESyne BDS Plus Drug Eluting Coronary Stent System for the Treatment of de Novo Native Coronary Artery Lesions	Phase 2	Unknown status (ClinicalTrials.gov)	Dec 15, 2021	Dec 2, 2022 (actual)
NCT04375085	DESyne X2 Post Market Follow-up Study	Not phased (device or behavioral study)	Terminated	Sep 1, 2020	Dec 28, 2021 (actual)
NCT02086006	Elixir Medical Clinical Evaluation of the DESolve Myolimus Eluting Bioresorbable Coronary Stent System - DESolve I Trial	Not phased (device or behavioral study)	Completed	2011-02	2016-10 (actual)
NCT02086045	Elixir Medical Clinical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - The DESolve Nx Trial	Not phased (device or behavioral study)	Completed	2011-11	2013-06 (actual)
NCT03429894	Evaluation of a Thin Strut Metallic Stent: the Elixir DynamX Clinical Study	Not phased (device or behavioral study)	Completed	Nov 16, 2017	Sep 17, 2019 (actual)
NCT04034121	Elixir Medical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - Cx Registry	Not phased (device or behavioral study)	Completed	Jan 20, 2016	Jan 22, 2017 (actual)
NCT02869087	The DESappear Study: Drug Eluting Scaffold	Not phased (device or behavioral study)	Completed	Oct 10, 2016	Aug 28, 2018 (actual)
NCT02009956	EXCELLA Post-Approval Study	Not phased (device or behavioral study)	Completed	Feb 26, 2014	Mar 2, 2015 (actual)
NCT02453035	DESolve® X-Pand Global Post Market Registry	Not listed	Terminated	May 13, 2015	Mar 31, 2017 (actual)
NCT03634020	DynamX Sirolimus Study Sirolimus Eluting Coronary Bioadaptor System	Not phased (device or behavioral study)	Completed	Dec 10, 2018	Mar 8, 2021 (actual)
NCT02013349	DESolve Post-Approval Study	Not phased (device or behavioral study)	Completed	Apr 22, 2014	2015-10 (actual)
NCT00792753	Elixir Medical Clinical Evaluation of the Novolimus-Eluting Coronary Stent System: A Randomized Study "EXCELLA II STUDY"	Not phased (device or behavioral study)	Completed	2008-10	2011-11 (actual)